Binding of aryl hydrocarbon receptor (AhR) to AhR-interacting protein - The role of hsp90

被引:133
作者
Bell, DR [1 ]
Poland, A [1 ]
机构
[1] NIOSH, Hlth Effects Lab Div, Ctr Dis Control, Morgantown, WV 26505 USA
关键词
D O I
10.1074/jbc.M004236200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aryl hydrocarbon receptor (AhR) has been shown to interact with an immunophilin-like molecule known as AhR-interacting protein (AIP) and to enhance AhR function. We show here that AIP associates with AhR homologues from mouse and fish, which can bind ligands such as dioxin, but nonligand binding homologues from Caenorhabditis elegans or Drosophila do not bind to AIP. However, a minimal ligand-binding domain of the AhR is incapable of binding AIP. The binding of AIP to AhR in reticulocyte lysate shows several of the characteristics of an hsp90-dependent process, including sensitivity to geldanamycin and temperature and a requirement for ATP or nonhydrolyzable analogues. Purified AIP binds to the C terminus of hsp90, and mutation of a conserved basic residue in the tetratricopeptide repeats of AIP (K266A, analogous to K97A in protein phosphatase 5) abolishes binding to hsp90. Mutation of K266A in AIP reduces binding to AhR by 75-80%; the geldanamycin sensitivity of this complex shows that AhR stabilizes the AIP-hsp90-AhR complex. The alpha -helical C terminus of AIP, which is outside the tetratricopeptide repeat domain, is absolutely required for binding to AhR as shown by deletions of the C-terminal 5 amino acids or alanine-scanning mutagenesis, but it is not required for binding of AIP to hsp90. The data support a model where 1) AIP binds to both hsp90 and AhR; 2) hsp90 is required for AhR-AIP binding; and 3) the binding of AhR to AIP stabilizes the AIP-hsp90-AhR complex.
引用
收藏
页码:36407 / 36414
页数:8
相关论文
共 36 条
  • [1] Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes
    Barent, RL
    Nair, SC
    Carr, DC
    Ruan, Y
    Rimerman, RA
    Fulton, J
    Zhang, Y
    Smith, DF
    [J]. MOLECULAR ENDOCRINOLOGY, 1998, 12 (03) : 342 - 354
  • [2] The common tetratricopeptide repeat acceptor site for steroid receptor-associated immunophilins and Hop is located in the dimerization domain of hsp90
    Carrello, A
    Ingley, E
    Minchin, RF
    Tsai, S
    Ratajczak, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (05) : 2682 - 2689
  • [3] Carver LA, 1997, J BIOL CHEM, V272, P11452
  • [4] Characterization of the Ah receptor-associated protein, ARA9
    Carver, LA
    LaPres, JJ
    Jain, S
    Dunham, EE
    Bradfield, CA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (50) : 33580 - 33587
  • [5] The Ah receptor is a sensitive target of geldanamycin-induced protein turnover
    Chen, HS
    Singh, SS
    Perdew, GH
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 348 (01) : 190 - 198
  • [6] DEFINITION OF A MINIMAL DOMAIN OF THE DIOXIN RECEPTOR THAT IS ASSOCIATED WITH HSP90 AND MAINTAINS WILD-TYPE LIGAND-BINDING AFFINITY AND SPECIFICITY
    COUMAILLEAU, P
    POELLINGER, L
    GUSTAFSSON, JA
    WHITELAW, ML
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (42) : 25291 - 25300
  • [7] The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR-mediated protein-protein interactions
    Das, AK
    Cohen, PTW
    Barford, D
    [J]. EMBO JOURNAL, 1998, 17 (05) : 1192 - 1199
  • [8] Control of distal antennal identity and tarsal development in Drosophila by spineless-aristapedia, a homolog of the mammalian dioxin receptor
    Duncan, DM
    Burgess, EA
    Duncan, I
    [J]. GENES & DEVELOPMENT, 1998, 12 (09) : 1290 - 1303
  • [9] IMMUNE-SYSTEM IMPAIRMENT AND HEPATIC-FIBROSIS IN MICE LACKING THE DIOXIN-BINDING AH RECEPTOR
    FERNANDEZSALGUERO, P
    PINEAU, T
    HILBERT, DM
    MCPHAIL, T
    LEE, SST
    KIMURA, S
    NEBERT, DW
    RUDIKOFF, S
    WARD, JM
    GONZALEZ, FJ
    [J]. SCIENCE, 1995, 268 (5211) : 722 - 726
  • [10] Prolonged depletion of AH receptor without alteration of receptor mRNA levels after treatment of cells in culture with 2,3,7,8-tetrachlorodibenzo-p-dioxin
    Giannone, JV
    Li, W
    Probst, M
    Okey, AB
    [J]. BIOCHEMICAL PHARMACOLOGY, 1998, 55 (04) : 489 - 497